NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0310
0.00 (0.00%)
Nov 25, 2025, 4:00 PM EST
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $3.86 million as of November 26, 2025. Its market cap has decreased by -61.77% in one year.
Market Cap
3.86M
Enterprise Value
56.66M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 3.86M, a decrease of -98.86%. That is a compound annual growth rate of -85.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 3.86M | -83.66% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 537.74M |
| CytoDyn | 421.60M |
| Northwest Biotherapeutics | 383.27M |
| American Oncology Network | 363.17M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 297.57M |